Back to Results
First PageMeta Content
Rare diseases / Lipid storage disorders / Clinical research / Healthcare / National Institute for Health and Clinical Excellence / Quality of life / National Health Service / Health technology assessment / Quality-adjusted life year / Health / Medicine / Health economics


Enzyme replacement therapy for Gaucher’s disease The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher’s disease: a systematic review
Add to Reading List

Document Date: 2013-05-21 08:23:39

Open Document

File Size: 82,53 KB

Share Result on Facebook

City

Southampton / /

Company

Genzyme / MEDLINE / St Edmundsbury Press Ltd / National Specialist Commissioning Advisory Group / /

Country

United Kingdom / Wales / /

Currency

GBP / /

Event

Product Issues / /

Facility

University of Sheffield / National Institute / University of Leicester / University of Southampton / Cochrane Library / University of Birmingham / /

IndustryTerm

search strategies / treatment of symptomatic Gaucher’s disease / review protocol / treatment of Gaucher’s disease / health technologies / therapy for Gaucher’s disease / health technology assessments / /

MarketIndex

Severity Score / /

MedicalCondition

inherited disorder / Background Gaucher’s disease Gaucher’s disease / initial thrombocytopenia / thrombocytopenia causing fatigue / lung disease / III Gaucher’s disease / delayed puberty / severe disease / infections / severe progressive brain disease / orphan disease / III disease / necrosis / disease / untreated Gaucher’s disease / neurological manifestations / pain / Gaucher’s disease / I Gaucher’s disease / symptomatic Gaucher’s disease / /

MedicalTreatment

Enzyme replacement therapy / /

Organization

National Knowledge Service / University of Leicester / Department of Health Sciences / Clinical Excellence / National Screening Committee / University of Birmingham / National Institute for Health / National Institute for Health and Clinical Excellence / University of Sheffield / School of Health / Department of Health / NHS / University of Southampton / /

Person

John Powell / Aileen Clarke / Rob Riemsma / Sarah Llewellyn Lloyd / Chris Hyde / Sally Bailey / Ken Stein / Tom Walley / Peter Davidson / /

Position

Queen / Corresponding author Executive / existing Reference Manager / disease Executive / National Clinical Director / Editor-in-Chief / Professor / Manager database / Controller / R&D HTA Programme HTA Executive / /

Product

Cerezyme / enzyme / activity / /

Technology

Health Technology / review protocol / summary Health Technology / health technologies / 1 West Midlands Health Technology / NHS This technology / genotype / 24 Health Technology / /

SocialTag